The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Clinical and Epidemiologic Features of Guillain‐Barré Syndrome
Abstract
Guillain-Barré syndrome (GBS) is defined clinically as a peripheral neuropathy causing limb weakness that progresses for up to 4 weeks before reaching a plateau. The symptoms may be caused by inflammatory demyelination, axonal degeneration, or both. GBS occurs throughout the world, with a median incidence of 1.3 cases/100,000 population (range, 0.4-4.0). Males are more commonly affected than females, and there are peaks in young adults and the elderly. There is no clear seasonal association in Western countries, although this may be because the most frequent antecedent events, respiratory and enteric infections, have opposite seasonality. The most frequently identified cause of GBS is Campylobacter jejuni infection, which has been identified in up to 41% of patients and is associated with more severe disease and prolonged disability. Summer epidemics of GBS occur among children and young adults in Northern China and are particularly likely to be associated with C. jejuni infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of current diagnostic criteria for Guillain-Barr� syndrome
Asbury, A. K., & Cornblath, D. R. (1990) · Annals of Neurology · doi:10.1002/ana.410270707 · Cited by 1,905
Ho, T. W., Mishu, B., Li, C. Y., Gao, C. Y., Cornblath, D. R., Griffin, J. W., Asbury, A. K., Blaser, M. J., & McKhann, G. M. (1995) · Brain · doi:10.1093/brain/118.3.597 · Cited by 764
Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China
McKhann, G. M., Cornblath, D. R., Griffin, J. W., Ho, T. W., Li, C. Y., Jiang, Z., Wu, H. S., Zhaori, G., Liu, Y., Jou, L. P., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330402 · Cited by 625
(1997) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(97)80059-4 · Cited by 610
NEUROLOGICAL DISEASE IN AN ENGLISH CITY
(1967) · The Lancet · doi:10.1016/s0140-6736(67)91251-2 · Cited by 396
Diagnostic considerations in Guillain-Barr� syndrome
Asbury, A. K. (1981) · Annals of Neurology · doi:10.1002/ana.410090703 · Cited by 329
A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.
Winer, J. B., Hughes, R. A., & Osmond, C. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.5.605 · Cited by 297
Self-citationA prospective study of acute idiopathic neuropathy. II. Antecedent events.
Winer, J. B., Hughes, R. A., Anderson, M. J., Jones, D. M., Kangro, H., & Watkins, R. P. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.5.613 · Cited by 284
Self-citationMcKhann, G. M., Cornblath, D. R., Ho, T., Griffin, J. W., Li, C. Y., Bai, A. Y., Wu, H. S., Yei, Q. F., Zhang, W. C., Zhaori, Z., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)90606-p · Cited by 261
Kuroki, S., Saida, T., Nukina, M., Haruta, T., Yoshioka, M., Kobayashi, Y., & Nakanishi, H. (1993) · Annals of Neurology · doi:10.1002/ana.410330304 · Cited by 247
Cited by
Hughes, R. A., & Cornblath, D. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67665-9 · Cited by 1,676
Self-citationWillison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Peripheral neuropathies and anti-glycolipid antibodies
Willison, H. J. (2002) · Brain · doi:10.1093/brain/awf272 · Cited by 710
Sejvar, J. J., Kohl, K. S., Gidudu, J., Amato, A., Bakshi, N., Baxter, R., Burwen, D. R., Cornblath, D. R., Cleerbout, J., Edwards, K. M., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.06.003 · Cited by 652
Self-citationCampylobacter Species and Guillain-Barré Syndrome
Nachamkin, I., Allos, B. M., & Ho, T. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.555 · Cited by 590
The Epidemiology of Guillain-Barré Syndrome Worldwide
McGrogan, A., Madle, G. C., Seaman, H. E., & de Vries, C. S. (2009) · Neuroepidemiology · doi:10.1159/000184748 · Cited by 573
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Lasky, T., Terracciano, G. J., Magder, L., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392501 · Cited by 505
Updated assessment of the prevalence, spectrum and case definition of autoimmune disease
Hayter, S. M., & Cook, M. C. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.02.001 · Cited by 464
Mechanisms for the induction of autoimmunity by infectious agents
Wucherpfennig, K. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14235 · Cited by 435
Pathogenesis of Guillain–Barré syndrome
Hughes, R. A. C., Hadden, R. D. M., Gregson, N. A., & Smith, K. J. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00195-2 · Cited by 405
Self-citationHahn, A. F. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12308-x · Cited by 395
Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis
Unterman, A., Nolte, J. E. S., Boaz, M., Abady, M., Shoenfeld, Y., & Zandman-Goddard, G. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2010.08.001 · Cited by 391
The Guillain–Barré syndrome: a true case of molecular mimicry
Wim Ang, C., Jacobs, B. C., & Laman, J. D. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.004 · Cited by 326
Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes
Yuki, N. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00019-6 · Cited by 326
Regulatory T cells in multiple sclerosis and myasthenia gravis
Danikowski, K. M., Jayaraman, S., & Prabhakar, B. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0892-8 · Cited by 323
Guillain-Barré Syndrome Following Influenza Vaccination
Haber, P. (2004) · JAMA · doi:10.1001/jama.292.20.2478 · Cited by 254
Plasmapheresis in immunologically mediated polyneuropathies.
Kiprov, D. D., & Hofmann, J. C. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00028.x · Cited by 13
Metadata
- Authors
- Hughes, R. A. C., & Rees, J. H.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-12
- Volume
- 176
- Issue
- s2
- Pages
- S92-S98
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2126152861
- Cited by
- 456
- References
- 21
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.